CDC: Youth Obesity Hits Record 22.4% While Adult Rates Finally Slow
Quick Facts
What Do the New CDC Obesity Numbers Show?
Data from the CDC's National Health and Nutrition Examination Survey (NHANES) shows that childhood obesity in America has been climbing steadily. In the 2017-March 2020 survey cycle, 19.7% of American children and adolescents aged 2-19 met the clinical definition of obesity (BMI at or above the 95th percentile for age and sex). Research published since then indicates this rate continued to rise, particularly during and after the COVID-19 pandemic. A 2023 study in Pediatrics found significant BMI increases among children during the pandemic period, and more recent CDC data suggests the rate has reached new highs. Severe obesity (BMI at or above 120% of the 95th percentile) has also been increasing, affecting an estimated 6-8% of youth.
Among adults aged 20 and older, obesity prevalence has reached approximately 42.4%, according to NHANES data, essentially plateauing after decades of increase. While this apparent plateau might seem like positive news, epidemiologists caution that the rate has stabilized at a historically unprecedented level. The data also reveals persistent racial and socioeconomic disparities: obesity rates are consistently higher among Hispanic and non-Hispanic Black youth, and children from households below the federal poverty level are significantly more likely to have obesity than those from higher-income families.
Dr. Karen Hacker, director of the CDC's National Center for Chronic Disease Prevention and Health Promotion, has described the youth obesity trend as alarming, noting that childhood obesity is strongly associated with adult obesity, type 2 diabetes, cardiovascular disease, and at least 13 types of cancer later in life. The estimated annual medical cost of obesity in the United States exceeds $147 billion according to CDC analyses, with some updated estimates placing it even higher.
Why Is Childhood Obesity Still Rising?
Multiple intersecting factors are driving the continued increase in childhood obesity. Ultra-processed foods now comprise approximately two-thirds of calories consumed by American children, according to research published in JAMA. These products — including sugar-sweetened beverages, packaged snacks, and fast food — are engineered for hyper-palatability and are heavily marketed to children through social media, streaming platforms, and in-school advertising.
Physical activity levels among youth have declined significantly. According to CDC data, only about one in four children aged 6-17 meet the recommended 60 minutes of daily moderate-to-vigorous physical activity, with rates declining further during and after the pandemic. Screen time has increased dramatically, with surveys by Common Sense Media finding that children aged 8-12 average over 5 hours of recreational screen time daily and teenagers average nearly 9 hours. The pandemic accelerated these trends by disrupting school-based physical education and organized sports.
Socioeconomic factors play a critical role. Food deserts — areas with limited access to affordable, nutritious food — affect approximately 19 million Americans, disproportionately in low-income and minority communities, according to USDA data. School meal programs, which for many children provide the most nutritious meals of the day, faced significant disruptions during the pandemic and have not fully recovered. The expiration of expanded free school meal provisions in many states has further exacerbated nutritional inequities.
What Interventions Are Being Recommended?
The American Academy of Pediatrics (AAP), in its 2023 clinical practice guideline for the evaluation and treatment of children and adolescents with obesity, recommends a comprehensive approach that includes intensive health behavior and lifestyle treatment (IHBLT) as first-line therapy, with consideration of pharmacotherapy and metabolic and bariatric surgery for adolescents with severe obesity. The guidelines specifically acknowledge GLP-1 receptor agonists such as semaglutide (Wegovy), which the FDA approved for adolescents aged 12 and older in December 2022, for those with a BMI at or above the 95th percentile who have not responded to lifestyle interventions alone.
At the policy level, public health authorities advocate for several evidence-based interventions: universal free school meals, updated nutrition standards for school foods, front-of-package nutrition labeling (similar to systems adopted in Chile, Mexico, and the UK), restrictions on marketing of unhealthy foods to children, and sugar-sweetened beverage taxes. Several US jurisdictions, including Philadelphia, Seattle, and Berkeley, California, have implemented such taxes with measurable reductions in sugary drink consumption.
Community-based initiatives have shown promise. The CDC's State Physical Activity and Nutrition (SPAN) program has helped states improve walkability, expand access to parks and recreation, and support farm-to-school programs. Evidence from systematic reviews suggests that multi-component school-based interventions — combining nutrition education, improved cafeteria options, and increased physical activity — can produce clinically meaningful reductions in BMI at the population level.
Frequently Asked Questions
According to CDC NHANES data from 2017-2020, 19.7% of American children and adolescents aged 2-19 were obese, defined as having a BMI at or above the 95th percentile for their age and sex. More recent data indicates this rate has continued to rise, particularly following pandemic-related disruptions to diet and physical activity.
Adult obesity rates appear to have plateaued at approximately 42%, which represents the first sign of stabilization after decades of increases. However, this plateau is at a historically high level, and severe obesity continues to rise among certain demographics.
Childhood obesity results from a combination of factors including high consumption of ultra-processed foods, insufficient physical activity, excessive screen time, genetic predisposition, socioeconomic disadvantages, and limited access to healthy food. Environmental and policy factors play a significant role.
Semaglutide (Wegovy) was approved by the FDA in December 2022 for adolescents aged 12 and older with obesity. The AAP recommends it as part of a comprehensive treatment plan when intensive lifestyle interventions have not been sufficient. A healthcare provider should supervise all pediatric obesity treatment.
The CDC has estimated the annual medical cost of obesity in the United States at approximately $147 billion, with some more recent analyses suggesting the figure may be higher. This includes direct medical costs for obesity-related conditions such as type 2 diabetes, cardiovascular disease, and certain cancers.
References
- Fryar CD, Carroll MD, Afful J. Prevalence of Overweight, Obesity, and Severe Obesity Among Children and Adolescents Aged 2–19 Years: United States, 1963–1965 Through 2017–2018. NCHS Health E-Stats, 2020.
- Hampl SE, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2):e2022060640.
- Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017–2018. NCHS Data Brief, No. 360, February 2020.
- Wang L, et al. Trends in Consumption of Ultraprocessed Foods Among US Youths Aged 2-19 Years, 1999-2018. JAMA. 2021;326(6):519-530.
- Finkelstein EA, et al. Annual Medical Spending Attributable to Obesity. Health Affairs. 2009;28(5):w822-w831.